Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
See Remarks · Twist Bioscience Corp · Common Stock
Open-market sale
$128K reported value · 1.5% of prior position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
4 other actors traded the same direction within 14 days
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 42 | Finn Patrick JohnPresident and COO | Open-market sale | SELL | $347K 2,565 sh | Nov 5, 2026 traded Nov 3, 2026 | |
| 36 | Werner Robert F.Chief Accounting Officer | Open-market sale | SELL | $20K 148 sh | Nov 5, 2026 traded Nov 3, 2026 | |
| 39 | Green PaulaSVP of Human Resources | Open-market sale | SELL | $136K 1,007 sh | Nov 5, 2026 traded Nov 3, 2026 | |
| 42 | Leproust Emily M.Director, Chief Executive Officer | Open-market sale | SELL | $619K 4,573 sh | Nov 5, 2026 traded Nov 3, 2026 | |
| 36 | ARK Investment Management LLC13F filer | TRIM | SELL | $184.46M 1.79M sh | Aug 14, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $128,496
Cho Dennis filed this Form 4 reporting a open-market sale of TWST on Nov 3, 2026. It became public on Nov 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.